Madison Muller and Naomi Kresge | (TNS) Bloomberg News Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, alleviated heart failure symptoms in patients with obesity, according to a late-stage trial that adds to the drug’s potential benefits. A weekly dose reduced patients’ ills that can include shortness of breath,…Read More
Weightloss drug Wegovy reduces heart failure symptoms in obese patients
